Clinical Trials Directory

Trials / Completed

CompletedNCT03753464

The Role of Functional Epigenetic Modifications in Peri-Implantitis

The Role of Functional Epigenetic Modifications in Peri-Implantitis: A Pilot Clinical Study

Status
Completed
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
NYU College of Dentistry · Academic / Other
Sex
All
Age
20 Years – 90 Years
Healthy volunteers
Accepted

Summary

The aim of this pilot, exploratory, single blind clinical trial is to evaluate the epigenetic changes associated with peri-implantitis.

Detailed description

Twenty patients will be voluntarily enrolled in two groups: 10 healthy participants, and 10 participants with peri-implantitis. Periodontal and peri-implant clinical and radiographic measurements, as well as body mass index, medical and dental history will be recorded within the following timelines: at baseline (for both groups), and 6 months after baseline for the peri-implantitis group only. At baseline, gingival biopsies and blood will be harvested from: a) healthy gingival sites during either surgical removal of wisdom teeth or gingivoplasty, in the healthy group; and, b) from a peri-implantitis site during surgical treatment of peri-implantitis, and when possible, from a healthy gingival site within the same participant, in the peri-implantitis group. After harvesting of biopsies, peri-implantitis subjects will be re-evaluated 6 months after treatment. During the 6-month visit, if a second surgical treatment of peri-implantitis in the same implant treated at baseline is indicated as standard of care of the participant, a new gingiva biopsy and blood will be collected. Gingival biopsies and blood collected from each participant will be used to perform DNA methylation analysis.

Conditions

Interventions

TypeNameDescription
PROCEDUREGingival biopsy and blood sample collectionGingival and blood samples will be collected.

Timeline

Start date
2018-10-04
Primary completion
2019-07-02
Completion
2019-07-02
First posted
2018-11-27
Last updated
2024-07-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03753464. Inclusion in this directory is not an endorsement.